戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  association was particularly pronounced for paucibacillary cases (IRRPoisson = 0.82, 95% CI: 0.68, 0
2 s superior to that of Xpert in patients with paucibacillary disease and in patients with HIV.
3 ficant diagnostic challenges associated with paucibacillary disease and requires a more sensitive tes
4                                 Animals with paucibacillary disease have high cell-mediated immunity
5 s sensitivity is inadequate in patients with paucibacillary disease or HIV.
6 ne expression patterns in multibacillary and paucibacillary disease, no shift in T cell genes from Th
7  these assays lack the sensitivity to detect paucibacillary disease.
8                                           In paucibacillary forms of human tuberculosis, which are di
9 oche detected 95% of patients with more than paucibacillary (greater than 20 colonies) tuberculosis.
10 Clinical and microbiological reactivation of paucibacillary infection by TNF neutralization was assoc
11                                              Paucibacillary infection was established, recapitulating
12 proved containment of infection and a stable paucibacillary infection.
13 del was developed with leprosy group (either paucibacillary leprosy [PB] or multibacillary leprosy [M
14 ent was started on WHO multidrug therapy for paucibacillary leprosy along with antiinflammatory drugs
15 commended multidrug therapy for 6 months for paucibacillary leprosy and 12 months for multibacillary
16 tides showed IFN-gamma responses only in the paucibacillary leprosy and household contact groups, wit
17 mer peptides were observed in the blood of a paucibacillary leprosy patient.
18                                   Five of 10 paucibacillary leprosy patients were Quantiferon Gold (Q
19 a) secretion upon incubation with blood from paucibacillary leprosy patients, a group who limit M. le
20            The resulting spectrum spans from paucibacillary leprosy, characterized by vigorous pro-in
21                         In a study of mainly paucibacillary leprosy-affected sib-pair families from S
22 gely of infected epithelioid macrophages and paucibacillary lesions contain T cells but few bacteria.
23 e sought to develop and characterize a novel paucibacillary model in mice, which develops necrotic lu
24 es in low-resource settings and the inherent paucibacillary nature of mycobacterial disease in childh
25 iculties in obtaining sputum samples and the paucibacillary nature of the disease.
26  to its dependence on sputum samples and the paucibacillary nature of the disease.
27 confirm microbiologically in part due to the paucibacillary nature of the disease.
28 manifestations of Lyme disease; however, the paucibacillary nature of the spirochete in this environm
29 ten complicated by its nonspecific symptoms, paucibacillary nature, and the need for invasive specime
30  the bacilli and eliminate PCR inhibitors in paucibacillary nonrespiratory samples.
31                           Multibacillary and paucibacillary paratuberculosis are both caused by Mycob
32 feron (IFN-gamma) responses from both TB and paucibacillary (PB) leprosy patients and from healthy ho
33 DO-LID detected larger proportions of MB and paucibacillary (PB) leprosy than the alternative, the St
34 controls and between multibacillary (MB) and paucibacillary (PB) leprosy.
35  inadequate methods of pathogen detection in paucibacillary pediatric samples and lack of a child-spe
36 ch as extrapulmonary tuberculosis (EPTB) and paucibacillary PTB.
37 erium tuberculosis complex (MTBC) members in paucibacillary samples warranted further investigation o
38 osis significantly improves its detection in paucibacillary samples.
39 , the test sensitivity remains suboptimal in paucibacillary specimens that are negative for acid-fast
40 ed M. tuberculosis detection, especially for paucibacillary specimens.
41 used for direct testing of smear-negative or paucibacillary sputum samples.
42 notypic testing for complex drug resistance, paucibacillary sputum, response to treatment, and detect
43 iagnose various TB manifestations, including paucibacillary TB cases, in adults with good sensitivity
44 iatric TB cases, including extrapulmonary or paucibacillary TB cases.
45 ilable for HIV-infected individuals, in whom paucibacillary TB is common.
46  IGRA-positive, AFB smear-negative, and have paucibacillary TB.
47 patients, including those diagnosed with the paucibacillary, tuberculoid form of disease, can be clas
48                                 Diagnosis of paucibacillary tuberculosis (TB) including extrapulmonar
49                 To develop a murine model of paucibacillary tuberculosis for experimental chemotherap
50 re, it could be helpful for the diagnosis of paucibacillary tuberculosis.
51 ffected sibpairs with leprosy, mainly of the paucibacillary type.